CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
GlobeNewswire
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the..
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the..
· SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in..
•Regenerative Medicine Advanced Therapy (RMAT) designation follows phase I clinical trial results demonstrating that..